# To Evaluate the Safety and PK Characteristics in Healthy Volunteers-JW24107

> **NCT06816719** · PHASE1 · COMPLETED · sponsor: **JW Pharmaceutical** · enrollment: 47 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Treatment A: JW0106 1 tablet + C2101 1 tablet
- **DRUG:** Treatment B: JW0107 1 tablet

## Key facts

- **NCT ID:** NCT06816719
- **Lead sponsor:** JW Pharmaceutical
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-09-02
- **Primary completion:** 2024-11-02
- **Final completion:** 2024-11-12
- **Target enrollment:** 47 (ACTUAL)
- **Last updated:** 2025-02-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06816719

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06816719, "To Evaluate the Safety and PK Characteristics in Healthy Volunteers-JW24107". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06816719. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*